Inhibition of gastric cancer cell growth by arginine: Molecular mechanisms of action

Clinical Nutrition

Volumn 28, Issue 1, 2009, Pages 65-70

  Nanthakumaran, Shayanthan ^a   Brown, Iain ^a   Heys, Steven D ^a   Schofield, Andrew C ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

Apoptosis; Arginine; Caspase 8; Enteral nutrition; Gastric cancer; Stomach neoplasms

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; 4',6 DIAMIDINO 2 PHENYLINDOLE; ARGININE; CASPASE 8; COMPLEMENTARY DNA;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; ENZYME ACTIVITY; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; WESTERN BLOTTING;

APOPTOSIS; ARGININE; BLOTTING, WESTERN; CASPASE 8; CELL LINE, TUMOR; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TIME FACTORS;

EID: 59149091792     PISSN: 02615614     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clnu.2008.10.007     Document Type: Article

References (29)

1. Gilbert F.J., and Thompson A.M. The Scottish audit of gastric and oesophageal cancer steering group, Report for 1997-2000. Available from: (2002). [accessed 27.05.08]
2. Heys S.D., Walker L.G., Smith I., and Eremin O. Enteral nutritional supplementation with key nutrients in patients with critical illness and cancer: a meta-analysis of randomized controlled clinical trials. Ann Surg 229 (1999) 467-477
3. Beale R.J., Bryg D.J., and Bihari D.J. Immunonutrition in the critically ill: a systematic review of clinical outcome. Crit Care Med 27 (1999) 2799-2805
4. Heyland D.K., Novak F., Drover J.W., Jain M., Su X., and Suchner U. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 286 (2001) 944-953
5. Albina J.E., Caldwell M.D., Henry Jr. W.L., and Mills C.D. Regulation of macrophage functions by L-arginine. J Exp Med 169 (1989) 1021-1029
6. Hibbs Jr. J.B., Vavrin Z., and Taintor R.R. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 138 (1987) 550-565
7. Brittenden J., Heys S.D., and Eremin O. L-arginine and malignant disease: a potential therapeutic role?. Eur J Surg Oncol 20 (1994) 189-192
8. Park K.G., Hayes P.D., Garlick P.J., Sewell H., and Eremin O. Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet 337 (1991) 645-646
9. Park K.G.M., Heys S.D., Eremin O., and Garlick P.J. The effect of L-arginine on the growth and metabolism of an experimental lung cancer. Clin Res Clin Oncol 38 (1990) 1709-1715
10. Cho-Chung Y.S., Clair T., Bodwin J.S., and Berghoffer B. Growth arrest and morphological change of human breast cancer cells by dibutyryl cyclic AMP and L-arginine. Science 214 (1981) 77-79
11. Reynolds J.V., Thom A.K., Zhang S.M., Ziegler M.M., Naji A., and Daly J.M. Arginine, protein malnutrition, and cancer. J Surg Res 45 (1988) 513-522
12. Ma Q., Hoper M., Anderson N., and Rowlands B.J. Effect of supplemental L-arginine in a chemical-induced model of colorectal cancer. World J Surg 20 (1996) 1087-1091
13. Park K.G., Heys S.D., Blessing K., Kelly P., McNurlan M.A., Eremin O., et al. Stimulation of human breast cancers by dietary L-arginine. Clin Sci 82 (1992) 413-417
14. Appleton J. Arginine: clinical potential of a semi-essential amino. Altern Med Rev 7 (2002) 512-522
15. Merimee T.J., Lillicrap D.A., and Rabinowitz D. Effect of arginine on serum-levels of human growth-hormone. Lancet 2 (1965) 668-670
16. Fukumura D., and Jain R.K. Role of nitric oxide in angiogenesis and microcirculation in tumors. Cancer Metastasis Rev 17 (1998) 77-89
17. Lala P.K., and Chakraborty C. Role of nitric oxide in carcinogenesis and tumour progression. Lancet Oncol 2 (2001) 149-156
18. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65 (1983) 55-63
19. Brown I., Shalli K., McDonald S.L., Moir S.E., Hutcheon A.W., Heys S.D., et al. Reduced expression of p27 is a novel mechanism of docetaxel resistance in breast cancer cells. Breast Cancer Res 6 (2004) 601-607
20. Tepaske R., Velthuis H., Oudemans-van Straaten H.M., Heisterkamp S.H., van Deventer S.J., Ince C., et al. Effect of preoperative oral immune-enhancing nutritional supplement on patients at high risk of infection after cardiac surgery: a randomised placebo-controlled trial. Lancet 358 (2001) 696-701
21. Cohen G.M. Caspases: the executioners of apoptosis. Biochem J 326 Pt 1 (1997) 1-16
22. Power J.J., Dennis M.S., Redlak M.J., and Miller T.A. Aspirin-induced mucosal cell death in human gastric cells: evidence supporting an apoptotic mechanism. Dig Dis Sci 49 (2004) 1518-1525
23. Gu Q., Wang J.D., Xia H.H., Lin M.C., He H., Zou B., et al. Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer. Carcinogenesis 26 (2005) 541-546
24. Pegg A.E., and McCann P.P. Polyamine metabolism and function. Am J Physiol 243 (1982) C212-C221
25. Poulin R., Pelletier G., and Pegg A.E. Induction of apoptosis by excessive polyamine accumulation in ornithine decarboxylase-overproducing L1210 cells. Biochem J 311 Pt 3 (1995) 723-727
26. Takao K., Rickhag M., Hegardt C., Oredsson S., and Persson L. Induction of apoptotic cell death by putrescine. Int J Biochem Cell Biol 38 (2006) 621-628
27. Brune B., von Knethen A., and Sandau K.B. Nitric oxide and its role in apoptosis. Eur J Pharmacol 351 (1998) 261-272
28. Moriya R., Uehara T., and Nomura Y. Mechanism of nitric oxide-induced apoptosis in human neuroblastoma SH-SY5Y cells. FEBS Lett 484 (2000) 253-260
29. Umansky V., Ushmorov A., Ratter F., Chlichlia K., Bucur M., Lichtenauer A., et al. Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 APO-1/Fas. Int J Oncol 16 (2000) 109-117